Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALBLOC: Calcium Chloride for Uterine Atony Prevention
NCT05027048Phase 3Completed
- Sponsor
- Stanford University
- Start
- Apr 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcium chloride in uterine atony, postpartum hemorrhage (PPH), sponsored by Stanford University. Started Apr 2022; status: completed.
02
Drugs
calcium chloride
03
Conditions
uterine atonypostpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05027048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05027048.